BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28895844)

  • 1. Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis.
    Biasco L; Rothe M; Schott JW; Schambach A
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):737-752. PubMed ID: 28895844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
    Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
    Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy.
    Kohn DB
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):721-735. PubMed ID: 28895843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.
    Espinoza DA; Fan X; Yang D; Cordes SF; Truitt LL; Calvo KR; Yabe IM; Demirci S; Hope KJ; Hong SG; Krouse A; Metzger M; Bonifacino A; Lu R; Uchida N; Tisdale JF; Wu X; DeRavin SS; Malech HL; Donahue RE; Wu C; Dunbar CE
    Mol Ther; 2019 Jun; 27(6):1074-1086. PubMed ID: 31023523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
    Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration.
    Kurre P; Anandakumar P; Harkey MA; Thomasson B; Kiem HP
    Mol Ther; 2004 Jun; 9(6):914-22. PubMed ID: 15194058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Barcodes Facilitate Competitive Clonal Analyses In Vivo.
    Aranyossy T; Thielecke L; Glauche I; Fehse B; Cornils K
    Hum Gene Ther; 2017 Oct; 28(10):926-937. PubMed ID: 28847169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus and lentivirus vector design and methods of cell conditioning.
    Cooray S; Howe SJ; Thrasher AJ
    Methods Enzymol; 2012; 507():29-57. PubMed ID: 22365768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertional gene activation by lentiviral and gammaretroviral vectors.
    Bokhoven M; Stephen SL; Knight S; Gevers EF; Robinson IC; Takeuchi Y; Collins MK
    J Virol; 2009 Jan; 83(1):283-94. PubMed ID: 18945765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.
    Biasco L
    Hum Gene Ther; 2017 Dec; 28(12):1122-1129. PubMed ID: 29160103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
    Kustikova O; Fehse B; Modlich U; Yang M; Düllmann J; Kamino K; von Neuhoff N; Schlegelberger B; Li Z; Baum C
    Science; 2005 May; 308(5725):1171-4. PubMed ID: 15905401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Immunodeficiency through HSC Gene Therapy.
    Booth C; Gaspar HB; Thrasher AJ
    Trends Mol Med; 2016 Apr; 22(4):317-327. PubMed ID: 26993219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
    Doi K; Takeuchi Y
    Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
    Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
    Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of lentiviral vectors - concepts and practice.
    Schambach A; Baum C
    Curr Gene Ther; 2008 Dec; 8(6):474-82. PubMed ID: 19075630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anchored Lentiviral Vector Episomes for Stem Cell Gene Therapy in Fanconi Anemia.
    Verghese SC; Kurre P
    Curr Gene Ther; 2017; 16(5):329-337. PubMed ID: 28093967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the clonal repertoire of gene-corrected cells in gene therapy.
    Paruzynski A; Glimm H; Schmidt M; Kalle Cv
    Methods Enzymol; 2012; 507():59-87. PubMed ID: 22365769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral integration and human gene therapy.
    Bushman FD
    J Clin Invest; 2007 Aug; 117(8):2083-6. PubMed ID: 17671645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.